InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,995.23
(
-0.32%
)
US TECH 100
16,728.38
(
-1.23%
)
Dow Jones
37,956.47
(
0.48%
)
Brent Oil
86.70
(
0.32%
)
Bitcoin
64,624.87
(
1.76%
)
Post# of 4273
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

fsulevine

Send PM Follow Ignore
Followers 10
Posts 2083
Boards Moderated 0
Alias Born 05/15/2015

fsulevine

Re: buddwhyzer post# 2923

Wednesday, 10/18/2017 3:46:33 PM

Wednesday, October 18, 2017 3:46:33 PM

Post# of 4273
My experience having invested in Amarin when they were developing Vascepa has demonstrated to me that there can be a long haul, even when one is not at all expected. Everyone was expecting Amarin (AMRN) to be bought after Vascepa was approved. They are still going it alone to this point, 4 years after approval and 3+ years after launch.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up